Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria

Ploner, Ferdinand; Zacherl, Johannes; Wrba, Friedrich; Längle, F.; Bareck, Evelyne; Eisterer, Wolfgang; Kühr, Thomas; Schima, Wolfgang; Häfner, Michael; Brodowicz, Thomas

doi:10.1007/s00508-009-1278-4

Cited by 3 publications

(1 citation statement)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Die häufi gsten Subtypen im Retroperitonealraum sind Lipo-und Leiomyosarkome, während in viszeraler Lokalisation gastrointestinale Stromatumore (GIST) dominieren, die im folgenden nicht weiter behandelt werden, da sie ein anderes biologisches Verhalten zeigen und ein spezifi sches Vorgehen erfordern. (Empfehlungen zu Diagnose und Th erapie von GIST sind Th ema einer separaten Publikation [8]). …”

Section: Epidemiologie äTiologieunclassified

Konsensus Diagnose und Therapie von Weichteilsarkomen

Brodowicz¹,

Amann

Leithner³

et al. 2011

Wien Klin Wochenschr

Self Cite

View full text Add to dashboard Cite

Soft tissue sarcomas are heterogeneous tumours and relatively uncommon. There have been advances over the past years concerning pathology, clinical behaviour, diagnosis strategies and the treatment. To summarize these advances as well as making it public is one of the goals of the following consensus guidelines. But why do we need special guidelines for Austria? There are international guidelines published by the European Society of Medical Oncology (ESMO) and the National Comprehensive Cancer Network (NCCN). The cause is that we need an explanation of the matrix the ESMO and the NCCN gave according to our clinical practice, the local requirements and facilities in Austria. The following recommendations were drawn up following a consensus meeting of sarcoma specialists from the three high volume centres located at the medical universities in Austria. All fields of involved physicians from diagnosis to therapy worked together to know that soft tissue sarcomas are an interdisciplinary challenge and multimodal treatment is essential. For this reason, these guidelines not only explain but also give the state of the art and clear recommendations. One of the most important guidelines is that any patient with a suspected soft tissue sarcoma should be referred to one of the three university centres and managed by a specialist sarcoma multidisciplinary team. We hope that the consensus is helpful for the clinical practice and improves the quality of care for patients with soft tissue sarcomas in Austria.

show abstract

Section: Epidemiologie äTiologieunclassified